Earnings Feed
Start Free
Home/Filings/4/0001033025-06-000003
4//SEC Filing

PRAECIS PHARMACEUTICALS INC 4

Accession 0001033025-06-000003

CIK 0001033025operating
View on SEC.govCompany Profile

Filed

Jul 10, 8:00 PM ET

Accepted

Jul 11, 5:00 PM ET

Size

10.7 KB

Accession

0001033025-06-000003

Insider Transaction Report

Form 4
Period: 2006-07-10
PRAECIS PHARMACEUTICALS INCPRCS
GEFTER MALCOLM L PHD
DirectorChairman and CSO
Transactions
  • Tax Payment

    Common Stock, par value $.01 per share

    2006-07-10$3.01/sh−40,872$123,025→ 169,028 total
  • Exercise/Conversion

    Common Stock, par value $.01 per share

    2006-07-10$1.33/sh+92,500$123,025→ 209,900 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2006-07-10−92,500→ 0 total
    Exercise: $1.33From: 2006-07-10Exp: 2006-07-11→ Common Stock, par value $.01 per share (92,500 underlying)
Holdings

  • Common Stock, par value $.01 per share

    (indirect: By self for son)
    1,300
Footnotes (3)
  • [F1]Adjusted to reflect a 1-for-5 reverse stock split effected November 1, 2005.
  • [F2]Represents delivery of previously acquired shares to the Company in payment of the option exercise price.
  • [F3]The term of the option is ten years from the date of grant.

Documents

1 file

Issuer

PRAECIS PHARMACEUTICALS INC

CIK 0001033025

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001033025

Filing Metadata

Form type
4
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 5:00 PM ET
Size
10.7 KB
View on SEC.gov